314 related articles for article (PubMed ID: 27423420)
1. NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy.
Yue Z; Ma Y; You J; Li Z; Ding Y; He P; Lu X; Jiang J; Chen S; Liu P
Exp Cell Res; 2016 Oct; 347(2):261-73. PubMed ID: 27423420
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
[TBL] [Abstract][Full Text] [Related]
3. Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes.
You J; Yue Z; Chen S; Chen Y; Lu X; Zhang X; Shen P; Li J; Han Q; Li Z; Liu P
Acta Physiol (Oxf); 2017 May; 220(1):58-71. PubMed ID: 27614093
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner.
Meng G; Liu J; Liu S; Song Q; Liu L; Xie L; Han Y; Ji Y
Br J Pharmacol; 2018 Apr; 175(8):1126-1145. PubMed ID: 28503736
[TBL] [Abstract][Full Text] [Related]
6. SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity.
Feng X; Wang Y; Chen W; Xu S; Li L; Geng Y; Shen A; Gao H; Zhang L; Liu S
Aging (Albany NY); 2020 Mar; 12(5):4178-4192. PubMed ID: 32139662
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of NMNAT3 improves mitochondrial function and enhances antioxidative stress capacity of bone marrow mesenchymal stem cells via the NAD+-Sirt3 pathway.
Wang T; Zhang F; Peng W; Wang L; Zhang J; Dong W; Tian X; Ye C; Li Y; Gong Y
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34981121
[TBL] [Abstract][Full Text] [Related]
8. High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3.
Guo R; Liu N; Liu H; Zhang J; Zhang H; Wang Y; Baruscotti M; Zhao L; Wang Y
Phytomedicine; 2020 Mar; 68():153171. PubMed ID: 32018211
[TBL] [Abstract][Full Text] [Related]
9. SIRT3 improved peroxisomes-mitochondria interplay and prevented cardiac hypertrophy via preserving PEX5 expression.
Wang M; Ding Y; Hu Y; Li Z; Luo W; Liu P; Li Z
Redox Biol; 2023 Jun; 62():102652. PubMed ID: 36906951
[TBL] [Abstract][Full Text] [Related]
10. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3.
Pillai VB; Samant S; Sundaresan NR; Raghuraman H; Kim G; Bonner MY; Arbiser JL; Walker DI; Jones DP; Gius D; Gupta MP
Nat Commun; 2015 Apr; 6():6656. PubMed ID: 25871545
[TBL] [Abstract][Full Text] [Related]
11. Exogenous NADPH exerts a positive inotropic effect and enhances energy metabolism via SIRT3 in pathological cardiac hypertrophy and heart failure.
Qian K; Tang J; Ling YJ; Zhou M; Yan XX; Xie Y; Zhu LJ; Nirmala K; Sun KY; Qin ZH; Sheng R
EBioMedicine; 2023 Dec; 98():104863. PubMed ID: 37950995
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy.
Hafner AV; Dai J; Gomes AP; Xiao CY; Palmeira CM; Rosenzweig A; Sinclair DA
Aging (Albany NY); 2010 Dec; 2(12):914-23. PubMed ID: 21212461
[TBL] [Abstract][Full Text] [Related]
13. Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice.
Pillai VB; Bindu S; Sharp W; Fang YH; Kim G; Gupta M; Samant S; Gupta MP
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H962-72. PubMed ID: 26873966
[TBL] [Abstract][Full Text] [Related]
14. Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6.
Cai Y; Yu SS; Chen SR; Pi RB; Gao S; Li H; Ye JT; Liu PQ
FEBS Lett; 2012 Mar; 586(6):866-74. PubMed ID: 22449973
[TBL] [Abstract][Full Text] [Related]
15. SOX4 as a potential therapeutic target for pathological cardiac hypertrophy.
Bin S; Xinyi F; Huan P; Xiaoqin Z; Jiming W; Yi H; Ziyue L; Xiaochun Z; Zhouqi L; Bangwei Z; Jing J; Shihui L; Jinlai G
Eur J Pharmacol; 2023 Nov; 958():176071. PubMed ID: 37741429
[TBL] [Abstract][Full Text] [Related]
16. Nmnat3 Is Dispensable in Mitochondrial NAD Level Maintenance In Vivo.
Yamamoto M; Hikosaka K; Mahmood A; Tobe K; Shojaku H; Inohara H; Nakagawa T
PLoS One; 2016; 11(1):e0147037. PubMed ID: 26756334
[TBL] [Abstract][Full Text] [Related]
17. Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD.
Chen T; Liu J; Li N; Wang S; Liu H; Li J; Zhang Y; Bu P
PLoS One; 2015; 10(3):e0118909. PubMed ID: 25748450
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin 3 is essential for hypertension-induced cardiac fibrosis via mediating pericyte transition.
Su H; Zeng H; Liu B; Chen JX
J Cell Mol Med; 2020 Jul; 24(14):8057-8068. PubMed ID: 32463172
[TBL] [Abstract][Full Text] [Related]
19. Baicalin inhibits pressure overload-induced cardiac hypertrophy by regulating the SIRT3-dependent signaling pathway.
Cai Y; Jiang S; Huang C; Shen A; Zhang X; Yang W; Xiao Y; Gao S; Du R; Zheng G; Yan T; Craig Wan C
Phytomedicine; 2023 Jun; 114():154747. PubMed ID: 36931095
[TBL] [Abstract][Full Text] [Related]
20. Sirtuin 3 Deficiency Accelerates Hypertensive Cardiac Remodeling by Impairing Angiogenesis.
Wei T; Huang G; Gao J; Huang C; Sun M; Wu J; Bu J; Shen W
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
